Clinic Contacts
Opportunities
User Login
Co-Chairs

Stephanie Crossen, MD, MPH, UC Davis Pediatrics

Stephanie Crossen, MD MPH is a pediatric endocrinologist and Associate Professor of Clinical Pediatrics at the University of California, Davis. Her research leverages telehealth and digital health technology to improve care delivery and outcomes for youth with T1D, particularly those from marginalized groups or at risk for poor outcomes. Her current NIDDK-funded projects evaluate the impact of remote monitoring for patients not reaching A1c goals, telehealth-facilitated peer support for diabetes technology use among Latinx adolescents, and a telehealth transition-of-care intervention for young adults with public insurance. She is thrilled to be a part of the T1D Exchange QI Collaborative!

Halis Kaan Akturk, MD, Barbara Davis Center Adult

Dr. Akturk is an Associate Professor of Medicine and Pediatrics at the Barbara Davis Center for Diabetes, Adult Clinic, University of Colorado. His research interests are investigating new diabetes technologies and therapeutics in type 1 diabetes. He recently received the 2024 Rising Star Award from AACE (American Association of Clinical Endocrinology) for his contributions to type 1 diabetes care and research. He is the ADA (American Diabetes Association) Diabetes Technology Interest Group Communications Director and ADA Annual Scientific Sessions Planning Committee Co-Chair for Diabetes Technology Section.

Charter
Publication Committee Charter Publications Request Form
2025 Meeting Schedule
  • Tuesday February 18, 2-3pm EST
  • Tuesday May 27, 2-3pm EST
  • Tuesday August 26, 2-3pm EST
2024 Meeting Schedule
  • Friday February 9, 12-1pm EST
  • Tuesday May 7, 3-4pm EST
  • Tuesday August 27, 2-3pm EST
Meeting Minutes
General Information
Abstract Flow Chart Clinical Interest Form Committee Responsibilities Publication Flow Chart Publication Members Clinical Interests Publications Policy and Procedures
Writing Workflow with Deadlines
  • First/Senior author submits proposal manuscript idea to Coordinating Center
  • Coordinating Center reviews request for feasibility (2 weeks)
  • Coordinating Center analyst discusses analysis plan with first author (4 weeks)
  • Coordinating Center shares data package with first/senior author (4-6 weeks)
  • First/Senior author writes and submits first draft to Coordinating Center (8 weeks)
    Co-authors selected (2 weeks):

    • a. Coordinating Center and first/senior author selects co-authors based on data
      submission, clinical interest and presentation/publication history with
      T1DX-QI, OR
    • b. Coordinating Center invites PI to select co-authors
      Coordinating Center returns to co-authors for revisions (2 weeks)
  •  First/Senior author reviews, address feedback and returns to Coordinating Center
    (2 weeks)
  • Coordinating Center selects 3 reviewers from the Publication Committee for feedback based on clinical interest (2 weeks)
  • First/Senior author review, address feedback from Publication Committee (2 weeks)
  • Coordinating Center or First/Senior author submits to journal (2 weeks)